
The far-right Alternative for Germany (AfD) on Saturday drew ahead of Chancellor Friedrich Merz's conservatives in a new opinion poll.
Merz's Christian Democratic Union (CDU) and its Bavarian sister party, the Christian Social Union (CSU), dropped by one percentage point to 25% in the INSA poll for the Sunday edition of the Bild newspaper.
The AfD, Germany's largest opposition party, was unchanged from last week's survey on 26%. The anti-immigrant party is under investigation by domestic intelligence services for its extremist views, but surged to second place in the 2025 parliamentary election.
In third place were Merz's centre-left coalition partners in the Social Democratic Party (SPD), down one point to 13%.
The opposition Greens and The Left were also unchanged at 12% and 11% respectively.
The margin of error was 2.9 percentage points, with 1,199 respondents participating in the survey.
LATEST POSTS
- 1
From record warming to rusting rivers, 2025 Arctic Report Card shows a region transforming faster than expected - 2
Europe picks companies to help build Argonaut moon lander - 3
Instructions to Decide whether a Fender bender Legal counselor is Required for Your Particular Case - 4
Starship success, a private moon landing and more: The top 10 spaceflight stories of 2025 - 5
Let them eat (Taylor Swift) cake: The baker turning A-listers into life-size desserts
Countdown begins for long-awaited Artemis II moon mission
Israel’s 'Stonehenge’ not alone with near 30 similar sites, satellite imagery reveals
Manual for Individual accounting Rudiments for Fledglings
Extraordinary Guinness World Records That Will Astound You
Dark matter may be made of pieces of giant, exotic objects — and astronomers think they know how to look for them
Bayer reports positive results for blood thinner after 2023 setback
Charlotte faith leaders hold interfaith forum on Black and Palestinian solidarity
Effectiveness Uncovered: A Survey of \Smoothing out Your Errands\ Efficiency Application
Baby takes 1st steps after receiving groundbreaking gene-edited therapy












